Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Limited Survival Benefit and High Healthcare Utilization With AML-Directed Therapy in Older Patients With TP53 -Mutated Acute Myeloid Leukemia.
Journal: American journal of hematology
Published: March 19, 2026
Ontogeny and Natural History of Therapy-Related Clonal Hematopoiesis From a Multidisciplinary CHIP Clinic.
Journal: American journal of hematology
Published: March 06, 2026
Clinico-genomic characterization of RAS-mutant acute myeloid leukemia.
Journal: Annals of hematology
Published: September 03, 2025
Natural history of clonal haematopoiesis seen in real-world haematology settings.
Journal: British journal of haematology
Published: December 26, 2023
Prognostic heterogeneity and clonal dynamics within distinct subgroups of myelodysplastic syndrome and acute myeloid leukemia with TP53 disruptions.
Journal: EJHaem
Published: August 10, 2023
Clinico-genomic profiling and clonal dynamic modeling of TP53-aberrant myelodysplastic syndrome and acute myeloid leukemia.
Journal: Leukemia & lymphoma
Published: September 09, 2021
Rapid and Deep Remission Induced by Blinatumomab for CD19-Positive Chronic Myeloid Leukemia in Lymphoid Blast Phase.
Journal: JCO precision oncology
Published: January 28, 2021
MATR3 disruption in human and mouse associated with bicuspid aortic valve, aortic coarctation and patent ductus arteriosus.
Journal: Human molecular genetics
Published: January 10, 2015
Improved detection rate of cytogenetic abnormalities in chronic lymphocytic leukemia and other mature B-cell neoplasms with use of CpG-oligonucleotide DSP30 and interleukin 2 stimulation.
Journal: American journal of clinical pathology
Published: April 19, 2013
The Blk pathway functions as a tumor suppressor in chronic myeloid leukemia stem cells.
Journal: Nature genetics
Published: February 13, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026